Nothing Special   »   [go: up one dir, main page]

Wei et al., 2023 - Google Patents

Combination therapy of HIFα inhibitors and Treg depletion strengthen the anti‐tumor immunity in mice

Wei et al., 2023

View PDF @Full View
Document ID
14961518156822612862
Author
Wei P
Kou W
Riaz F
Zhang K
Fu J
Pan F
Publication year
Publication venue
European Journal of Immunology

External Links

Snippet

Hypoxia‐inducible factor 1 alpha (HIF1α), under hypoxic conditions, is known to play an oxygen sensor stabilizing role by exerting context‐and cell‐dependent stimulatory and inhibitory functions in immune cells. Nevertheless, how HIF1α regulates T cell differentiation …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation

Similar Documents

Publication Publication Date Title
Tang et al. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
Ni et al. YAP is essential for treg-mediated suppression of antitumor immunity
Pollizzi et al. mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation
Bowers et al. Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion
Jacobs et al. IL-7 is essential for homeostatic control of T cell metabolism in vivo
Parish et al. Chronic viral infection promotes sustained Th1-derived immunoregulatory IL-10 via BLIMP-1
Shono et al. A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity
Stromnes et al. Abrogating Cbl-b in effector CD8+ T cells improves the efficacy of adoptive therapy of leukemia in mice
Luo et al. Foxo transcription factors in T cell biology and tumor immunity
Chen et al. IKKα is required for the homeostasis of regulatory T cells and for the expansion of both regulatory and effector CD4 T cells
Sarmento et al. A novel role for Kruppel-like factor 14 (KLF14) in T-regulatory cell differentiation
Liu et al. A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment
Zhao et al. IL-36β promotes CD8+ T cell activation and antitumor immune responses by activating mTORC1
Chung et al. DC-HIL-expressing myelomonocytic cells are critical promoters of melanoma growth
Li et al. Bcl6 preserves the suppressive function of regulatory T cells during tumorigenesis
Nakayama et al. Lymphotoxin-beta receptor blockade induces inflammation and fibrosis in tolerized cardiac allografts
Dai et al. SARI attenuates colon inflammation by promoting STAT1 degradation in intestinal epithelial cells
Guo et al. Lung adenocarcinoma‐related TNF‐α‐dependent inflammation upregulates MHC‐II on alveolar type II cells through CXCR‐2 to contribute to Treg expansion
Liu et al. Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinoma
Schutt et al. The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease
Jiang et al. Intrinsic RIG-I restrains STAT5 activation to modulate antitumor activity of CD8+ T cells
Wei et al. Combination therapy of HIFα inhibitors and Treg depletion strengthen the anti‐tumor immunity in mice
Chen et al. Protein disulfide isomerase a4 promotes lung cancer development via the Stat3 pathway in stromal cells
Li et al. Dominant negative TGF-β receptor type II in T lymphocytes promotes anti-tumor immunity by modulating T cell subsets and enhancing CTL responses
Koliesnik et al. RelB regulates Th17 differentiation in a cell-intrinsic manner